Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)
Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)
Recruiting · NCT07584083 · Registry updated 2026-06-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial) | antiphospholipid syndrome, autoimmune disease, immune system disorder | Recruiting | Phase 2 | 2026-06-02 | NCT07584083 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| National and Kapodistrian University of Athens | 74 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Laiko General Hospital | Athens | Greece | 1 |